Current Cancer Drug Targets

Aims & Scope

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

"This journal fills an important need in providing reviews, covering the moving area of new cancer drug targets"

Paul Workman
CRC Centre for Cancer Therapeutics, England

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

Related E-Books

Bentham ebook::Animated Atlas of Oncology

Bentham ebook::Cancer Metastasis and Cancer Stem Cell/Niche

Bentham ebook::Cancer Preventive and Therapeutic Compounds: Gift From Mother Nature

Bentham ebook::Avastin and Malignant Gliomas

Bentham ebook::Cutting Edge Therapies for Cancer in the 21 Century

Bentham ebook::Cancer Immunotherapy: Mechanisms of Cancer Immunity, Engineering Immune-Based Therapies and Developing Clinical Trials

Bentham ebook::Systems Biology in Cancer Immunotherapy

Bentham ebook::Frontiers in Clinical Drug Research - Anti-Cancer Agents

Bentham ebook::Lung Cancer: Clinical and Surgical Specifications

Bentham ebook::Malignant Pleural Mesothelioma: Present Status and Future Directions

Bentham ebook::Molecular Aspects of Hepatocellular Carcinoma

Bentham ebook::Molecular Mechanism and Morphology in Cancer

Bentham ebook::Molecular Oncology: Principles and Recent Advances

Bentham ebook::Multiple Myeloma - A New Era of Treatment Strategies

Bentham ebook::Nutrition and Cancer From Epidemiology to Biology

Bentham ebook::Physiopathogenesis of Hematological Cancer

Bentham ebook::Recent Advances in Angiogenesis and Antiangiogenesis

Bentham ebook::The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis

Bentham ebook::Theory in the Pathophysiology of Carcinogenesis

Bentham ebook::Therapeutic Revolution The History of Medical Oncology from Early Days to the Creation of the Subspecialty

Bentham ebook::Thyroid Cancer: A Clinical Overview and A Useful Laboratory Manual

Bentham ebook::Topics in Anti-Cancer Research

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More

Welcome To
Current Cancer Drug Targets

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers

Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors

Macrophage Flipping from Foe to Friend: A Matter of Interest in Breast Carcinoma Heterogeneity Driving Drug Resistance

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients’ Outcome

The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine

Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Endorsement(s)

Announcements

Related Journals

Related E-Books

About Publisher

Bentham Science: About Us

Indexed in

Welcome To Current Cancer Drug Targets

About the Journal

Aims & Scope

Meet Our Editorial Board Member

Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers

Focal Adhesion Kinase in Ovarian Cancer: A Potential Therapeutic Target for Platinum and Taxane-Resistant Tumors

Macrophage Flipping from Foe to Friend: A Matter of Interest in Breast Carcinoma Heterogeneity Driving Drug Resistance

Efficacy and Safety of Antigen-specific Immunotherapy in the Treatment of Patients with Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis

Tumor-dependent Effects of Proteoglycans and Various Glycosaminoglycan Synthesizing Enzymes and Sulfotransferases on Patients’ Outcome

The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine

Cathepsin L Induces Proangiogenic Changes in Human Omental Microvascular Endothelial Cells via Activation of the ERK1/2 Pathway

Endorsement(s)

Announcements

Related Journals

Related E-Books

About Publisher

Bentham Science: About Us

Indexed in

Welcome To
Current Cancer Drug Targets